Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.003 Å; R factor = 0.048; wR factor = 0.130; data-to-parameter ratio = 12.9.
In the molecular structure of the title compound, C 16 H 13 N 3 , the cyclohexa-1,3-diene ring displays a screw-boat conformation and the pyridine ring is twisted by a dihedral angle of 29.13 (9) with respect to the pyrazole ring. Molecules are linked into a supramolecular structure by N-HÁ Á ÁN hydrogen bonding.
Related literature
For general background to indazole derivatives and their pharmacological properties, see: Bistochi et al. (1981) ; Keppler & Hartmann (1994) ; Sun et al. (1997) ; Gomtsyan et al. (2008) .
Experimental
Crystal data Mo K radiation = 0.08 mm À1 T = 293 (2) K 0.22 Â 0.19 Â 0.18 mm
Data collection
Bruker SMART CCD area-detector diffractometer Absorption correction: none 24926 measured reflections 2217 independent reflections 1978 reflections with I > 2(I) R int = 0.036 Refinement R[F 2 > 2(F 2 )] = 0.048 wR(F 2 ) = 0.130 S = 1.08 2217 reflections 172 parameters H-atom parameters constrained Á max = 0.44 e Å À3 Á min = À0.25 e Å À3 Table 1 Hydrogen-bond geometry (Å , ).
Symmetry code: (i) x À 1 2 ; Ày þ 1 2 ; Àz.
Data collection: SMART (Bruker, 2002); cell refinement: SAINT (Bruker, 2002); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 for Windows (Farrugia, 1997); software used to prepare material for publication: WinGX (Farrugia, 1999). Indazole derivatives exhibit variety of pharmacological properties such as anti-inflammatory (Bistochi et al., 1981 ), antitumor (Keppler et al., 1994 ), anti-HIV (Sun et al., 1997 and analgesic (Gomtsyan et al., 2008) . Herein we present the crystal structure of the title indazole derivative.
3-(4-
The crystal structure of the title compound is represented in Fig. 1 . the C10-containing cyclohexa-1,3-diene ring displays a screw-boat conformation, and the pyridine ring is twisted to pyrazole ring with a dihedral angle of 29.13 (9)°. Intermolecular N-H···N hydrogen bonding presents in the crystal structure (Table 1) .
Experimental
A solution of 3,4-dihydronaphthalen-1(2H)-one (1.46 g, 0.01 mol) was added to a stirred solution of hydrazine (0.05 g, 0.01 mol) in dry tetrahydrofuran (50 ml) at 273 K for 3 h. Then n-butyllithium (0.02 mol) was added at a fast dropwise rate during a 5 min period at 273 K. The solution was stirred at 273 K for an additional 30 min, then methyl isonicotinate (1.37 g, 0.01 mol) dissolved in 40 ml of THF was added to the dilithiated intermediate, and the solution was stirred for 1 h at 273 K. Finally, 20 ml of 3 M hydrochloric acid was added, and the two phase mixture was well stirred and heated under reflux for 45 min. The mixture was then neutralized with solid sodium bicarbonate, and the layers were separated. The aqueous layer was extracted with ether. The organic fractions were combined, evaporated, the crude product was dissolved in methanol (60 ml). The solution was filtered and the filtrate was set aside for three weeks to obtain colorless single crystals of the title compound.
Refinement
H atoms were placed in calculated positions with C-H = 0.93 or 0.97 Å, N-H = 0.86 Å, and refined in riding mode with U iso (H) = 1.2U eq (C,N). (11) 0.0499 (10) −0.0028 (9) −0.0010 (9) 0.0031 (8) C5 0.0331 (8) 0.0480 (9) 0.0496 (9) −0.0036 (7) −0.0023 (7) −0.0032 (7) C7 0.0375 (9) 0.0422 (9) 0.0447 (9) −0.0016 (7) −0.0033 (7) −0.0008 (7) C12 0.0474 (10) 0.0449 (9) 0.0474 (9) −0.0077 (8) 0.0013 (7) −0.0040 (7) C8 0.0379 (9) 0.0430 (9) 0.0504 (10) 0.0011 (7) −0.0024 (7) 0.0020 (7) C6 0.0361 (8) 0.0416 (9) 0.0498 (9) −0.0019 (7) −0.0022 (7) 0.0007 (7) C4 0.0412 (9) 0.0455 (10) 0.0585 (10) −0.0024 (7) 0.0045 (8) supplementary materials sup-6 Fig. 1 
